Form 4 for ANIX Anixa Biosciences Inc
Accepted 2025-01-15 00:00:00 ET · period of report 2025-01-15 · accession 0001493152-25-002314 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-15 | 2025-01-15 | ANIX | Catelani Michael | Pres, COO, CFO | P - Purchase | $2.15 | +9,289 | 44.5K | +26% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | P | A | 9,289 | $2.15 | 44,500 | D | — | — |